BioSpace News Archive

JLL has been recognized by global biopharmaceutical company Bristol-Myers Squibb with a Service Delivery Excellence Award announced at the company’s annual Global Suppliers Conference.

Total revenue for the three months ended September 30, 2017 was $3M compared to $5.5M for the three months ended September 30, 2016.

Medidata announced today that Akros Pharma has entered into an additional multi-year platform agreement, further expanding their 10-year old partnership to improve the efficiency and efficacy of their clinical trials.

“Following another record quarter, with double-digit revenue and profit growth, we are well positioned to finish 2017 strongly and continue our momentum into 2018,” said Matthijs Glastra, CEO.

The completion of these transactions improves Windtree’s balance sheet and better positions the Company to raise the capital needed to fund continued development of AEROSURF for RDS and potentially its pipeline of surfactant products utilizing its proprietary KL4 surfactant and aerosol device technologies.

Synthetic Biologics today provided an operational update and reported financial results for the three months ended September 30, 2017.

The Company’s strategy of increasing its focus on new customers in the much larger “Early Majority” market segment resulted in new customers representing three-quarters of the all-tissue laser systems sales during the third quarter of 2017.

Foundation Medicine reported total revenue of $42.7 million in the third quarter of 2017, compared to $29.4 million in the third quarter of 2016.

MilliporeSigma today announced the signing of a Memorandum of Understanding with Samsung BioLogics for a strategic alliance on biopharma manufacturing and biologics process development.

Biohaven and its wholly owned subsidiary, Biohaven Pharma, today announced that the FDA has notified the Company that it may proceed with its clinical investigation of sublingual BHV-0223 as a potential treatment for patients with ALS.